Drug Profile
Mizagliflozin - Kissei Pharmaceutical
Alternative Names: KWA 0711Latest Information Update: 01 Oct 2019
Price :
$50
*
At a glance
- Originator Kissei Pharmaceutical
- Class Amides; Antihypoglycaemics; Laxatives; Pyrazoles; Small molecules
- Mechanism of Action Sodium-glucose transporter 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Constipation
Most Recent Events
- 01 Oct 2019 Chemical structure information added
- 28 Jun 2018 No recent reports of development identified for phase-I development in Constipation(In volunteers) in United Kingdom (PO)
- 15 Apr 2016 Kissei Pharmaceutical completes a phase I trial in Constipation (In volunteers) in United Kingdom (NCT02434835) prior to April 2016